Skip to main content
Clinical Trials/NCT01651884
NCT01651884
Completed
Phase 1

High Definition-transcranial Direct Current Stimulation (HD-tDCS) for Stroke Rehabilitation

Soterix Medical0 sitesMarch 2012
ConditionsChronic Aphasia

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Chronic Aphasia
Sponsor
Soterix Medical
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The purpose of this study is to assess the changes in language processing of patients with chronic aphasia after receiving non-invasive brain stimulation.Previous research using traditional transcranial direct current stimulation (tDCS) using 2 sponge electrodes has shown that persons with aphasia show more improvement after treatment when that treatment is accompanied by brain stimulation. Traditional tDCS has recently been modified to deliver current to more specific locations in the brain. This new delivery method is called high-definition tDCS (HD-tDCS). It is not known whether traditional tDCS (more diffuse current delivery) or HD-tDCS (more focal current delivery) will be the better approach for enhancing treatment outcomes. To answer this question, computerized speech-language treatment will be administered during the application of the different forms of brain stimulation.

Registry
clinicaltrials.gov
Start Date
March 2012
End Date
January 2013
Last Updated
10 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
Soterix Medical
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • one-time ischemic stroke in the left hemisphere
  • greater than 6-months post-stroke onset
  • between 25 and 80 years of age
  • aphasia diagnosis (as determined by pre-treatment language-based testing)
  • right-handed (before the stroke)
  • native speaker of English
  • ability to provide informed written or verbal consent

Exclusion Criteria

  • clinically reported history of dementia, alcohol abuse, psychiatric disorder, traumatic brain injury, or extensive visual acuity or visual-spatial problems
  • factors contraindicative of tDCS administration (sensitive scalp, previous brain surgery)
  • prior history of epileptic or unprovoked seizures occurring during the previous 12 months.

Outcomes

Primary Outcomes

Not specified

Similar Trials